ASPC
A SPAC III Acquisition Corp.10.50
-0.05-0.52%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
24.53MP/E (TTM)
-Basic EPS (TTM)
-0.34Dividend Yield
0%Recent Filings
10-K
FY2025 results
A SPAC III Acquisition Corp. posted FY2025 net income of $1.3M, flipping to profit from 2024's $0.2M loss, driven by $2.2M interest income on trust investments less $0.8M G&A expenses; no operations yet. Trust balance dwindled to $3.0M by year-end after October 2025 EGM redemptions of 5.7M shares for $59.5M, leaving Sponsor owning 76%. Q4 saw merger signing with Bioserica for $218M in stock, pending close by November 2026 deadline. Cash sat at $0.9M with positive working capital. Bioserica deal risks PRC regulatory hurdles.
8-K
Sponsor swaps into 76.4% Class A
A SPAC III Acquisition Corp. swapped 1,499,900 Class B shares held by sponsor A SPAC III (Holdings) Corp. for equal Class A shares on January 16, 2026, under their Exchange Agreement. Sponsor now controls 76.4% of outstanding Class A shares, with total Class A at 2,337,481. Shares carry prior restrictions like transfer limits and pro-business combination voting. Unregistered under Section 3(a)(9). Sponsor dominates.
10-Q
Q3 FY2025 results
A SPAC III swung to a $480k net income for Q3 ended September 30, 2025, up from a $39k loss y/y, thanks to $654k interest income on its $62.3M trust account crushing $174k admin costs—while non-redeemable shares took a $0.11 hit from redemptions accretion. Nine-month net income hit $1.3M versus last year's $47k loss, with cash at $1.1M and no debt after repaying sponsor note. Signed May 2025 merger for Bioserica at $218M (all stock: 20M Class B, 1.8M Class A shares at $10), pending conditions; extended deadline to November 2026 post-redemptions. Trust intact. Merger deal breakers loom.
8-K
SPAC extends combination deadline
A SPAC III Acquisition Corp. extended its deadline to complete an initial business combination by 12 months to November 12, 2026, after shareholders approved the charter amendment at an October 27, 2025 extraordinary general meeting. With 4,178,733 votes in favor against 2,934,951 opposed, 5,717,419 shares were redeemed, leaving the SPAC with fewer public shares. The sponsor secured support from a third party by promising 100,000 Class B shares post-combination. This buys time, yet redemptions shrink the trust.
10-Q
Q2 FY2025 results
A SPAC III Acquisition Corp. posted a net income of $379,939 for Q2 FY2025 ended June 30, 2025, up sharply from a $8,000 loss a year earlier, thanks to $646,975 in interest income from its $61.6M trust account, while general and administrative expenses climbed to $267,036 from $8,000 on heightened public company costs. Year-to-date through June 30, net income hit $793,141 versus a $8,000 loss last year, with interest income at $1.3M offsetting $500,914 in expenses; redeemable shares earned $0.22 per share on 6M shares, but non-redeemable shares absorbed a $0.24 loss per share on 2.055M shares due to accretion charges (derived). Cash stood at $1.1M outside the trust, with no debt after repaying a related-party note, supporting merger pursuits. On May 23, 2025, the company signed a merger deal with Bioserica International for $217.9M in stock (20M Class B and 1.786M Class A shares at $10 each, assuming $12.5M third-party investment), involving a reincorporation merger and Bioserica as a wholly owned subsidiary, backed by a shareholder voting agreement. Geopolitical tensions could disrupt the deal.
AACI
Armada Acquisition Corp. II
10.29-0.01
ALSAF
Alpha Star Acquisition Corporat
17.50+0.00
BSAA
BEST SPAC I Acquisition Corp.
10.10+0.00
GPAT
GP-Act III Acquisition Corp.
10.66+0.00
HSPT
Horizon Space Acquisition II Co
10.62+0.06
IPCX
Inflection Point Acquisition Co
10.11+0.00
NPAC
New Providence Acquisition Corp
10.28+0.03
SPEG
Silver Pegasus Acquisition Corp
10.07-0.01
SPKL
Spark I Acquisition Corp.
11.23+0.08
SVII
Spring Valley Acquisition Corp.
12.70+0.00